All 2026 2025 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

12345678下一頁 >

• 2026/01/05 InnoPharmax Submits Phase II Trial Application for D07001 (GemOral) to TFDA.
• 2026/01/02 InnoPharmax BendaReady Approved as New Bendamustine Formulation in Taiwan.
• 2025/12/09 Sapropterin Dihydrochloride Tablets Added to China’s Commercial Insurance Drug List.
• 2025/07/14 InnoPharmax-Licensed Gadopentetate Injection Wins 26-Province VBP Bid in China.
• 2025/07/09 InnoPharmax Partners with U.S. CRO for Global Phase III Trial of D07001-Softgel.
• 2025/04/10 Completion of Stage 1 in the Phase II/III Clinical Trial of D07001 Softgel Capsules for Advanced Biliary Tract Cancer.
• 2025/02/05 InnoPharmax Completes First-Stage Enrollment for D07001 Softgel Capsules in Advanced Biliary Tract Cancer Phase II/III Trial.
• 2024/12/13 InnoPharmax Licensed Gadopentetate Injection Wins Hebei Tender in December.
• 2024/12/10 InnoPharmax Advances D07001 to Phase III for Cholangiocarcinoma.
• 2024/12/02 InnoPharmax Licensed Gadoterate Injection Approved by NMPA in China.

12345678下一頁 >